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Unpacking the Placebo Response: 
Insights from Ethnographic Studies of Healing
Laurence J. Kirmayer, MD *
This paper selectively reviews cross-cultural studies of healing to identify parallels with the process 
of responding to placebos in biomedical contexts. Placebo responses involve positive therapeutic 
effects of symbolic stimuli that may be mediated by changes in cognition and attention as well as 
psychophysiological mechanisms. Ethnographic studies of healing point to additional social and 
cultural processes that may mediate and modulate placebo responding, including: (i) the cogni-
tive and social grounding of believed-in-efficacy and expectations; (ii) interpersonal processes of 
narrating and re-negotiating symptom and illness experience; and (iii) the embedding of healing 
in cultural ontologies, values and social institutions that define positive health outcomes and that 
govern the esthetics and rhetorical power of healing interventions. Research on the social-contex-
tual basis of placebo responding can contribute to an integrative theory of healing. Because placebo 
responding is part of any therapeutic intervention, there is no theoretical or practical justification 
for the deceptive use of placebos. Strengthening the components of placebo responding inherent 
in clinical effectiveness will insure maximum benefit for patients and maintain the credibility and 
fidelity of medical practitioners and institutions.
Introduction
There is increasing recognition that the use of pla-
cebos is not simply an ethical or pragmatic prob-
lem in medicine but points toward fundamental 
insights into the nature of healing.  The term “pla-
cebo” is used in at least three distinct but related 
ways: (i) to label a beneficial therapeutic response 
to a treatment that is believed to have no direct 
biological activity; (ii) to label the control arm in a 
clinical trial in which an active treatment is com-
pared to a biologically inert treatment; and (iii) to 
refer to any therapeutic response to treatment 
that is assumed to be mediated by expectations or 
other symbolic processes.  These three uses reflect 
separate strands in the history of medicine as well 
as different clinical and experimental contexts 
in which placebos are used (Harrington, 2006). 
There have been efforts to devise terminology 
that recognizes these different uses, distinguish-
ing placebos (an inactive or inert treatment), from 
placebo effects (the group difference between out-
comes when active treatment and inactive treat-
ment groups are compared in clinical trials) and 
placebo responses (individual's responses to a sym-
bolic intervention) (Price, Finniss & Benedetti, 
2008).  However, these different uses of the term 
“placebo” are closely related: the assumption that 
placebos are inactive treatments stands behind 
the use of placebos as controls in clinical trials 
which aim to subtract "nonspecific effect" from 
actual efficacy through statistical comparison. 
Of course, the evidence that placebos actually do 
have positive therapeutic effects means that any 
treatment may owe its efficacy in part to specific 
psychological or symbolic processes that imediate 
placebo responding.  
Miller and Kaptchuk (2008) suggest re-con-
ceptualizing placebo effects as contextual heal-
ing.  This has the virtue of encouraging us to think 
about all of the aspects of the clinical context 
that might contribute to beneficial physiologi-
cal, cognitive, emotional, and social responses to 
any treatment (Benedetti, 2011; Linde, Fässler & 
Meissner, 2011).  These responses are not “non-
specific” but involve specific mechanisms that may 
be evoked by particular cues.  Placebo responding 
stands at the heart of the symbolic efficacy of all 
forms of medicine (Brody, 2010).  Although most 
research on placebos has focused on psychological 
and psychophysiological processes, studying the 
social contexts of healing can illuminate the inter-
personal and wider social determinants of placebo 
response.  As this paper will argue, understand-
ing the effectiveness of placebos and other healing 
interventions requires knowledge of the person’s 
social world, contexts and commitments.
The sections that follow first consider some 
epistemological and methodological issues and 
then briefly review work on the great variety of 
mechanisms that may underlie placebo respond-
ing.  The section on healing as placebo, summa-
rizes some useful insights that have come from an-
thropological efforts to develop a general theory of 
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symbolic or ritual healing.  Turning this analogy 
around, the next section considers the clinical and 
experimental use of placebos as a type of symbol-
ic healing ritual.  This includes some reflections 
on the ways in which placebos are viewed in bio-
medicine, which are tied to emerging notions of 
neurological personhood.  The final section out-
lines some implications for ethical and pragmatic 
issues in clinical practice of understanding pla-
cebo responding as embodied processes that are 
socially situated and culturally mediated.
Clinical and experimental 
epistemics of placebo
Speaking of an intervention as a placebo draws 
attention to the externally administered agent, 
often a pill or some other visible form of treat-
ment.  This encourages the observer to attribute 
any healing efficacy to the intervention itself. 
Because the placebo treatment is, by definition, 
inert, this poses a puzzle.  If the placebo really has 
no (biological) effect, those who claim to benefit 
must be dissimulating or simply gullible, talking 
themselves into something that is not really hap-
pening.  More accurately, since the placebo has 
no immediate biological activity, if it has some 
physiological effect, this must be through some 
causal chain of psychophysiological processes 
that translate symbolic meaning into physiologi-
cal response.
Clinical trials often involve comparing an ac-
tive treatment to an inactive (placebo) control. 
Of course, this experimental paradigm does not 
measure the placebo effect per se, because any 
improvement over time in the group receiving 
the placebo may reflect a myriad of other factors 
associated with the course of the condition be-
ing treated, including unmeasured effects of the 
environment or host responses.  To identify the 
placebo effect itself, we must compare a group 
given a placebo (a biologically inactive treat-
ment) to a group not receiving any treatment at 
all (Ernst & Resch, 1995; Hrόbjartsson, Kaptchuk, 
& Miller, 2011).  Indeed, we can begin to disen-
tangle components of placebo responding by 
varying this comparison: for example, giving one 
group an inert pill with a strong positive message 
(“This will make your headache go away”) and 
another group the same message but a differently 
colored pill*.  We can also measure the strength 
of individuals’ expectations of improvement and 
see whether this correlates with positive outcome. 
Alternatively, in the “open–hidden” drug treat-
ment paradigm devised by Benedetti (2009), the 
response of subjects who are aware they are re-
ceiving an active treatment is compared to that of 
subjects who are unaware they are receiving the 
same treatment.  Any difference between groups 
can then be attributed to psychologically medi-
ated responses†.
These types of experiment can help identify 
the parameters that influence placebo effects and 
point to the underlying processes that may medi-
ate placebo responses including cognitive expec-
tations, emotional arousal, and the impact of rela-
tionships (Finniss, Kaptchuk, Miller & Benedetti, 
2010).  A growing body of work of this type has 
produced some surprising results that challenge 
conventional medical understandings of placebo. 
In particular, the “hidden drug versus open drug 
paradigm” makes it clear that a large part of the 
observed efficacy of many drug treatments comes 
from their symbolic effects (Benedetti, 2008). 
Being given a medication surreptitiously does 
not have the same degree of benefit as knowing 
one is taking it.  Placebo effects then are part of 
every medical treatment and may account for a 
substantial part of any observed benefit.  Calling a 
treatment a “placebo”, while often meant as a dis-
missal, actually points to the endogenous healing 
capacities of human beings, which deserve inten-
sive study and systematic incorporation into ev-
ery aspect of medical care. 
Varieties of placebo  
responding
Although references to “the placebo effect” im-
ply a unitary phenomenon, there are as many 
types of placebo responding as there are forms 
of learning and adaptation that can give rise to 
physiological anticipation or psychological ex-
pectation.  We can organize these varieties of 
placebo responding in terms of specific physio-
logical systems (autonomic, endocrine, immune, 
motor, pain, etc.), expected effects (e.g., analge-
sia, anxiety reduction, mood elevation, impact 
on specific disease processes), or contexts (type 
of medical system, health care setting, religious 
ritual, etc.) (Benedetti, 2008; Benedetti, Carlino, 
& Pollo, 2011; Linde, Fässler & Meissner, 2011; 
Meissner, 2011; Pollo, Carlino & Benedetti, 2011; 
Pollo, Finniss & Benedetti, 2008).  Alternatively, 
drawing from hierarchical systems theory, we can 
think of placebo effects in terms of the level of 
regulatory process and the corresponding medi-
ating mechanisms that are influenced by learn-
ing, cognition or social interaction (Figure 1; See 
Kirmayer, 2004). 
At the level of psychological mediation, pla-
cebo effects have been explained in three broad 
ways as a result of (i) enhancing positive emo-
tions and optimism, (ii) reducing anxiety and 
other negative emotions that cause distress, 
and (iii) shaping attentional and interpretive or 
 
* The colour, size and shape 
of pills can influence the 
placebo response. Surpris-
ingly, this fact seems to be 
ignored sometimes not only 
by clinicians but also by 
pharmaceutical companies 
(Khan, Bomminayuni, Bhat, 
Faucett, & Brown, 2010).
 
† Of course, the difference 
between “open” and “hid-
den” administration is not 
clear-cut because, for ethical 
and pragmatic reasons, 
people usually know they 
are in a situation where 
this may happen. Similarly, 
participants in placebo trials 
may be able to detect some 
aspects of the intervention 
based on subtle sensory 
or other cues. While this 
can be controlled for by 
debriefing and post-hoc 
statistical analysis, it reflects 
an important set of issues 
related to the ways that cul-
tural systems — in this case 
the instrumental rationality 
of modernity — influence 
individuals’ attention to the 
body and interpretation of 
sensations, symptoms and 
clinical interventions. 
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attributional processes that give meaning to ex-
perience (Geers, Weiland, Kosbab, Landry, & 
Helfer, 2005).  Clearly, these mediators can inter-
act in many ways.  Positive and negative emotions 
may compete for attention and mutually suppress 
each other.  Attention and interpretation are in-
fluenced by emotional state but also can give rise 
to positive or negative emotions, setting up feed-
back loops.  All of these potential mediators may 
be influenced by other cognitive, affective and 
motivational processes.
Although we think of expectations as con-
scious processes, there are various kinds of ex-
pectation or anticipatory responding that involve 
non-conscious mechanisms based on learning 
processes mediated by specific neural systems. 
For example, placebo analgesia involves the 
activation of endogenous opioid pain control sys-
tems in the brainstem (Levine, Gordon & Fields, 
1978).  Indeed, much of the individual variability 
in response to both opiate and non-opiate anal-
gesics may be determined by individual differ-
ences in the response of endogenous opiate pain-
modulation systems (Amanzio, Pollo, Maggi & 
Benedetti, 2001).  Placebo responding to analge-
sics also involves additional top-down influences 
from frontal cortex acting on rostral anterior cin-
gulate cortex, along pathways that do not involve 
endogenous opioid neurotransmission (Petrovic 
et al., 2010).  Placebo analgesia involves activation 
of an internal regulatory system that normally 
functions to control pain.  These systems have 
multiple effects so that, for example, placebo ef-
fects on enhancing memory may also be mediat-
ed by endorphins (Stern et al., 2011).  Similar sys-
tems exist for regulating inflammatory processes 
and various autonomic, endocrine and immune 
functions and these may provide the basis for a 
variety of specific placebo responses (Ader, 1997; 
Meissner, 2011; Pollo, Cariino, & Bendetti, 2011).  
Placebo responses may also be mediated by 
classical or Pavlovian conditioning (Stewart-
Williams & Podd, 2004; Wickramasekera, 1980). 
Classical conditioning is based on adaptive re-
sponses (e.g., salivating in anticipation of eat-
ing to aid in the digestion of food) that can be 
linked to new contextual stimuli.  Physiological 
responses that are linked to stimuli by classical 
conditioning tend to have a compensatory physi-
ological function that reflects specific regulatory 
systems (Siegel, 2002).  For example, a sensory 
cue that has been linked to the presentation of 
food, triggers the release of insulin in anticipa-
tion of eating.  Other classically conditioned re-
sponses are based on linking symbolic stimuli to 
specific responses of regulatory systems.  
Classical conditioning has been shown for 
a wide range of physiological responses involv-
ing motor, autonomic, endocrine and immune 
systems, each of which may mediate specific 
types of placebo response (Ader, 1997).  These 
mechanisms could build associations between 
particularly environmental cues and physiologi-
cal responses that have clinical significance.  The 
strength and direction of these responses will de-
pend in part on each individual’s learning history, 
which in turn will reflect culturally-patterned 
frameworks of meaning, as well as shared and id-
iosyncratic experiences.  Classically conditioned 
effects constitute forms of non-conscious expec-
tations or predispositions to respond that are part 
of each individual’s enculturation and personal 
biography.  Similarly, other forms of operant 
and sensory-associative learning can link salient 
stimuli to bodily responses (Hinton, Howes & 
Psychophysiological 
processes
Bodily sensations
Attention
Self-monitoring
Attribution and 
interpretation
Emotion regulation & 
expression of distress
Response of Others
Symptom reduction
Healing & well-being
Classical conditioning
Sensory associative 
learning 
Learning to direct 
attention
Cognitive models
Coping strategies
Relationship, trust, 
comfort and concern
Level of 
Regulatory Process
Mediator of 
Placebo Response
Figure 1. Levels of Regulation and Varieties of Placebo Response.  Regulatory processes 
involved in placebo responding may be mediated and modified by learning mechanisms that 
operate at multiple levels. See Kirmayer (2004).
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Kirmayer, 2008).  These embodied processes of 
learning can contribute to placebo responding 
even in the absence of awareness (Frenkel, 2008). 
Of course, cognitive and classically conditioned 
learning processes usually coexist and interact 
and, in some situations, cognitive expectations 
may trump classically conditioned effects (Kirsch, 
2004). 
Attentional mechanisms also may play a cen-
tral role in placebo responses.  Focusing attention 
on discomfort can intensify symptoms and, con-
versely, distraction, or absorption in other sensa-
tions, imagery or activity can markedly reduce 
symptoms like pain, nausea and other forms of 
discomfort (Pennebaker, 1982).  This attentional 
capacity may underlie some of the phemonena 
associated with clinical hypnosis (Raz, 2007; 
Raz & Buhle, 2006).  Suggestions and expecta-
tions, whether direct or implicit can guide atten-
tion.  Focus of attention and expectations inter-
act in symptom experience (Cioffi, 1991; Geers, 
Weiland, Helfer & Kosbab, 2007; Geers, Wellman, 
Fowler, Rasinski, & Helfer, 2011).
Expectations generally involve cognitive 
models or frameworks and affective attitudes or 
stances.  These models can be encoded as stories, 
propositions, metaphors or images that may be 
explicit (conscious) or implicit (non-conscious). 
Both implicit and explicit cognitive models can 
direct thinking in ways that amplify or diminish 
symptomatology and distress.  Indeed, cogni-
tion can influence symptoms through the ways 
in which sensations are focused on, interpreted, 
labeled and attributed (Kirmayer & Sartorius, 
2007).  These processes represent levels or sites 
where the symbolic effects of placebos may exert 
effects.  Because attributional processes are cen-
tral to symptom experience, any suggestion, in-
struction or contextual cue that shifts attention, 
attributions and coping responses will, in turn, 
change symptom experience.  These shifts can 
occur through reattribution, engaging with new 
images or metaphors, or re-narrating distress in a 
new story frame. 
Social interaction is a powerful vehicle for 
conveying treatment expectations.  Modeling 
and observational learning can result in placebo 
effects that are stronger than those elicited by 
direct verbal suggestion (Colloca & Benedetti, 
2009).  The doctor–patient relationship involves 
all of these cognitive, emotional influences but 
therapeutic relationships can have additional ef-
fects through neurobiological mechanisms that 
are fundamental to human sociality (Benedetti, 
2010).  For example, experiences of trust can 
stimulate brain oxytocin release, which increases 
feelings of comfort and trust, with potentially 
far-reaching effects on well-being, interpersonal 
relationships and long-term health outcomes. 
This feedback loop from quality of relationships 
to physiology and back, depicted in Figure 1, is 
just one of many such potential loops, which 
may involve larger social processes.  Of course, 
relationships of trust are embedded in larger so-
cial structures.  For some marginalized groups, 
mistrust in health care institutions and profes-
sionals may reduce help-seeking and undermine 
the effectiveness of interventions, thus aggravat-
ing the health disparities associated with social 
inequities.
The social-psychological processes involved 
in placebo responding are not specific to place-
bos; they apply to any treatment.  Moreover, indi-
viduals' psychological and interpersonal respons-
es are embedded in larger sociocultural systems 
that give meaning to experience.  Changes in the 
social meaning of specific treatments can, in turn, 
reshape expectations vastly increasing or under-
mining confidence and hope.  There may be com-
plex social patterns of anticipation that depend 
on interactions with others, social contextual 
cues, and cultural systems of meaning which are 
taken for granted or used more or less automati-
cally because they are embodied and embedded 
in social practices.  Based on cultural and per-
sonal meanings, people may invest in a treatment 
because it is consonant with their values and mo-
tivations and respond positively because of the 
emotional meaning of the treatment (Hyland & 
Whalley, 2008).
Thompson and colleagues (2009) suggest that 
placebo responses can reflect embodied learning 
and contextual responding that are independent 
of consciousness awareness.  The symbolic, af-
fective and esthetic responses to treatments can-
not be reduced to expectations; they are part of 
cultural performance and participation (Myers, 
2010).  This means that responses to placebos or 
other treatment interventions need not be based 
on cognitive models or representations carried by 
the individual but may be part of a performance 
that involves distributed knowledge and that 
therefore can only be enacted through concerted 
social action.  These enactments depend on in-
teractions with others who are essential to create 
the context and shape the response.  In this sense, 
placebo responses may be understood as social 
phenomena that depend on embodied experi-
ence, socially distributed or embedded knowl-
edge, and situated practice.
Healing ritual as placebo
There is a vast anthropological literature on heal-
ing rituals in diverse cultures.  Much of this has 
focused on the esthetics of performance and 
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explored the parallels between healing practices 
and larger cultural myths, values and social struc-
tures (Csordas & Lewton, 1998).  The actual effec-
tiveness of healing has been examined less often, 
but authors have attributed the potential efficacy 
of ritual to nonspecific effects of meaning, expec-
tation and belief that may be related to placebo 
effects (Frank, 1961; Moerman, 2002). 
Ethnographic studies of healing emphasize 
the multiple sources and complex dynamics of be-
lief and expectation, the interpersonal processes 
of renegotiating illness and healing experiences, 
and the embedding of healing practices in larger 
cultural ontologies and ideologies of the person 
(Kleinman, 1980; Kirmayer, 2004; Waldram, 
2008).  These ontologies recognize different types 
of agency or influence as sources of healing effica-
cy.  For example, in different systems of medicine, 
spirits, humors, “energies”, chemicals, or human 
relationships may be invoked as a powerful medi-
ator of effective healing.  These notions of agency 
are part of larger cultural differences in notions 
of the person that shape the diagnostic systems, 
goals and methods of healing (Kirmayer, 2007)..
There are many reasons why people may be-
lieve in the potential efficacy of a treatment and 
have positive expectations.  These sources of hope 
and conviction include: the causal logic of the 
treatment, which may be grounded in a specific 
ontology or simply part of an extended metaphor 
that is popular, appealing or compelling; the ex-
tent of individuals' investment in the larger heal-
ing system, which may be part of religious or oth-
er cultural identities, values and commitments; 
the degree to which they reject conventional bio-
medicine and, therefore, are open to alternative 
systems of medicine that challenge the hegemony 
of biomedicine; and, especially, compelling expe-
riences of their own or of others that seem to dem-
onstrate impact and positive outcomes (Kirmayer, 
2006).  These expectations or believed-in-efficacy 
then give rise to a variety of responses that can 
contribute to positive outcomes. 
The classic account of expectancy effects in 
healing is found in the work of social psychia-
trist Jerome Frank (1961).  Frank identified four 
components common to all systems of healing 
that were part of a “shared assumptive world” 
between sufferer and healer: theories of afflic-
tion with particular ontologies; defined roles 
for healers which confer healing power, author-
ity and legitimacy; a designated place and time 
for healing (often imbued with sacred qualities); 
and the symbolic action of the healing ritual 
which aims to transform the status of the sick 
person.  Frank saw positive expectations (based 
on a “shared assumptive world” and the evoca-
tive power of healer, context, and treatment) as 
reducing “demoralization” — a  common dimen-
sion of many forms of affliction.  In later versions 
of his theory, he considered a diversity of healing 
processes relevant to specific conditions (Frank & 
Frank, 1991).  He also came to see the relevance of 
studies of rhetoric which examine how commu-
nication can persuade and transform experience 
(Frank, 1995). 
The study of rhetoric takes on new signifi-
cance in societies with high levels of cultural 
diversity where Frank’s notion of a shared as-
sumptive world is challenged.  In contemporary 
societies, people often participate in systems of 
healing with little shared experience or under-
standing of the specific tradition.  The appeal of 
these heterodox traditions must be explained by 
the persuasive power of rhetoric and the imagi-
native appeal of novel models and metaphors for 
illness and healing (Kaptchuk & Eisenberg, 1998; 
Kirmayer, 2006). 
In an influential paper on the effectiveness 
of symbolic healing, the anthropologist Claude 
Lévi-Strauss (1963) considered how a shamanic 
ritual could evoke physiological changes.  For 
Levi-Strauss the formal analogy or parallels be-
tween the structure of the healing ritual and the 
patients’ experience accounted for the healing 
transformation.  In effect, the patient’s experience 
of bodily affliction was mapped by analogy onto a 
mythic landscape (Figure 2).  This mapping might 
occur through divination or other forms of diag-
nosis before or during the healing ritual, which 
sometimes takes the form of a search for the na-
ture of the affliction.  Traversing this mythic land-
scape in image, narrative or metaphor through 
ritual incantations, the healer or his spirit guide 
Sufferer
Afflicted Healed
Mythic Realm
Symbol of 
Affliction
Symbol of 
Healing
Ritual
narrative 
Bodily 
experience
Figure 2. The Structural Logic of Healing Ritual.  The 
healing ritual maps the sufferer’s bodily experience onto a 
mythic realm where it can be transformed by ritual action, 
structured according to a culturally coherent narrative. Trans-
formation at the level of the mythic narrative then works to 
transform the afflicted person’s bodily experience, self-un-
derstanding and social identity from sick to healed. Based on 
Lévi-Strauss (1967). See also Kirmayer (1993).
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then moves from a place representing affliction to 
one that corresponds to health.  This metaphor-
ic movement somehow causes corresponding 
changes in attention, cognition and experience 
that result in healing.
The appeal of Lévi-Strauss’s account lies in its 
formal structure but this also is its limitation.  The 
process of healing seems under-theorized and the 
mechanisms involved remain unclear (Kirmayer, 
1993).  In the actual example of Kuna shamans 
used by Lévi-Strauss, the patient does not under-
stand the healer’s incantations, hence the impact 
of the ritual must be through non-linguistic as-
pects of the healing performance.  Nevertheless, 
the notion that healing involves a transformative 
process mediated by the evocation of and partici-
pation in a mythic or “virtual world” remains a 
useful way to understand the rich symbolism and 
formal structure of healing practices (Kapferer, 
2005). 
Anthropologist James Dow (1986) addressed 
the question of the dynamics of healing, building 
on the work of Lévi-Strauss, with the suggestion 
that the transformative effects occur by attaching 
experience to emotionally meaningful symbols. 
It is the moving quality of emotion itself that ul-
timately does the psychophysiological or psycho-
logical work.  Rituals then exert their effects by 
influencing emotional experience.  This fits with 
observations that healing rituals often are struc-
tured like dramatic performances that elicit emo-
tional catharsis (Scheff, 1979).  It is also consistent 
with studies showing that part of placebo respond-
ing may be mediated by changes in emotional 
state (Flaten, Aslaksen, Lyby, & Bjørkedal, 2011). 
In my own work, I have extended these mod-
els to consider how the metaphors of healing map 
experience onto images or mythic narratives with 
different sensory, affective and cognitive quali-
ties (Kirmayer, 1993, 2003, 2004, 2008).  There is 
now a wealth of research showing how metaphors 
emerge from bodily experience and how employ-
ing a metaphor can, in turn, change bodily sen-
sations, cognition and action (Barsalou, 2008; 
Gibbs, 2006).  Metaphors mediate bodily expe-
rience and overarching mythic narratives that 
are viewed as compelling or sacred truths.  The 
metaphoric elaboration of experience can occur 
through listening and imaginative representation 
or through ritual enactment.  
In a healing ritual, the sufferer’s experience 
is mapped analogically onto a metaphoric rep-
resentational space (Figure 3).  The initial repre-
sentation is extended and transformed according 
to the metaphoric logic and imagery of the ritual. 
The transformed representation is embodied and 
enacted by the afflicted person.  In practice, this 
occurs as an ongoing cycle of embodiment and 
enactment throughout the healing ritual and in 
subsequent re-experiencing, recollection and nar-
ration of the ritual or its expected consequences.  
Esthetics play an important role in healing 
rituals, making the performance attractive, com-
pelling, absorbing or entrancing*.  Esthetic ele-
ments of the ritual portray the predicament of 
the suffering person and dramatize the transition 
from darkness and affliction to goodness, posi-
tivity, health and harmony (Kapferer & Papigny, 
2005).  The form, structure and sensory qualities 
of healing can convey specific metaphoric quali-
ties (e.g., vigor, strength, power) (Kirmayer, 1993, 
2008).  These metaphors influence processes of 
attention, cognition and behaviour that bring the 
anticipated mode of experiencing into being and 
amplify its intensity. 
Healing rituals have received so much ethno-
graphic attention not only because of their claims 
for efficacy, but also because of their dramatic 
and arresting qualities.  The arcane, numinous, 
rhetorically skillful and authoritative aspects of 
ritual performance are all strategies for mobiliz-
ing symbolic power which has social, emotional 
and cognitive dimensions.  The power of ritual is 
often bodily-felt in ways that convey a sense of 
immediacy and conviction that something signif-
icant is happening.  The power that healing rituals 
mobilize is often understood as not simply social 
or physiological but as drawing from spiritual or 
transcendental realms. 
All of this theoretical work must be set against 
the observation that healing rituals often do not 
work — at least not as advertised or expected.  A 
 
* The etymology of the word 
empathy, from the German 
Einfühlung stems from 
this experience of esthetic 
absorption.
Figure 3. Healing Performance as Metaphoric Transformation.  The sufferer’s illness experi-
ence is mapped analogically onto a representational space (in literary terms, from metaphoric 
topic to vehicle). The initial representation is extended and transformed according to the meta-
phoric logic and imagery of the ritual. The transformed representation (metaphier) is embodied 
and enacted by the afflicted person. See: Kirmayer (1993, 2003).
Sufferer’s Experience
Topic Metaphrand
Metaphoric Representation
Vehicle Metaphier
Metaphoric 
transformation
Analogy
Enactment
Embodiment
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study of healing by Chinese shamans (dang-ki) 
in Singapore, found that many of the people re-
sorting to this form of ritual healing did not have 
strong beliefs or expectations in the treatment; 
they sought out the healer with some tentative 
hope or open-minded interest to see if it might 
work (Lee, Kirmayer, & Groleau, 2010).  People 
sought evidence during and after the healing that 
something significant had happened, noticing 
changes in bodily sensations or other signs.  In 
many cases, the healing did not work quite as ex-
pected.  While some people then gave up on the 
healer, many preserved their hope and commit-
ment by identifying another change in symptoms 
or life events that they interpreted as a positive 
sign of healing efficacy.  In this way, they could 
preserve and strengthen a belief in the healing ef-
ficacy.  The pragmatic, tentative, subjunctivizing 
(“What if it works?”) stance, the active search for 
evidence of effectiveness, and the shifting criteria 
for positive outcome seen in this ethnographic 
study are probably not unique to this particular 
cultural context but are features of help-seeking 
in many contemporary settings and healing sys-
tems, including biomedicine.
Placebo as ritual healing
Examining the parallels between ritual healing 
and placebo administration can advance our 
understanding of the mechanisms of placebo re-
sponse.  Noting that most of the clinical contexts 
where placebos are used can be viewed as rituals, 
Brody proposed a “meaning model” of placebo 
responding, suggesting that a positive therapeu-
tic response occurs when the patient: (i) feels 
listened to and attended to by the caregiver; (ii) 
receives an explanation of the illness that is con-
sistent with his or her own worldview; (iii) feels 
care and compassion from the helper or healer; 
and (iv) experiences an increased sense of mas-
tery or control over the illness (Brody, 2010, p. 
161).  Like Frank before him, Brody assumes that 
shared, culturally grounded notions of illness and 
healing govern the relationship with the healer. 
Through enacting and affirming shared ontolo-
gies “the performance of a healing ritual becomes 
a bodily enactment of reconnection with the 
community” (Brody, 2010, p. 162).
Consistent with contemporary Western no-
tions of psychotherapy, Brody emphasizes the 
positive effects of supportive, caring and compas-
sionate emotional relationships.  In fact, many 
forms of traditional healing do not involve much 
listening, communication or explicit support to 
the patient.  These modes of healing must mo-
bilize other social processes to facilitate healing. 
Much ritual healing is aimed not at the suffering 
individual but at their social and spiritual context. 
It aims to put right the sociomoral world of the 
afflicted person, as well as that of his or her fam-
ily and community (Turner, 1977).  This may be 
deemed successful even if the patient continues 
to be symptomatic.
Brody summarizes his view of placebo as the 
outcome of medical ritual in this way:
“A simple way of expressing what we 
know about the placebo response is that 
the human brain seems to be hard-wired 
to get better in illness, and that certain 
sorts of mental stimuli seem capable of 
turning on this hard-wired system to 
produce symptom relief.  The elements 
that make up ritual seem to be especially 
effective in turning on the wiring cir-
cuits.” (p. 163)
Though deliberately phrased in simple lan-
guage that makes no claim for scientific precision, 
it is instructive to consider the implications of 
Brody’s choices of metaphor because similar lo-
cutions are common in both mass media and the 
medical literature.  My aim in unpacking Brody’s 
account is not to take him more literally than he 
intends, but to show how the metaphors in this 
passage convey certain common assumptions 
about mind, brain and personhood that influence 
the way that both professionals and patients think 
about placebos. 
First, Brody emphasizes an endogenous 
“hard-wired” healing system or mechanism. 
Although he uses the singular (“the hard-wired 
system”), clearly there are multiple regulatory 
systems involved and, in most treatment con-
texts, multiple systems will be activated and inter-
act to give rise to any observed effects.  More sig-
nificantly, he brackets off the developmental and 
learning history of these systems by calling them 
“hard-wired”.  In describing the effect of these 
systems, Brody uses grammar that implies it is 
the brain that gets better.  This metonymic use of 
the brain for the person is increasingly common 
in popular and scientific discourse (Vidal, 2009). 
Of course, placebo effects do involve alterations 
in brain chemistry and function (Benedetti, 2011). 
Generally speaking, though, it is not the brain 
that is afflicted and that gets better in healing but 
the person.  This distinction is important because 
the person is much more than a brain and its reg-
ulatory systems.  The person includes cognitive 
processes that are embodied, socially embedded, 
and enacted and hence, not reducible to the brain 
(Kirmayer & Gold, 2011).  Moreover, it is not sim-
ply illness that is modified by ritual healing but 
sickness — that is, the sufferer’s social identity as 
a person with an affliction (Young, 1992).  This is 
why healing may be judged successful even when 
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symptoms and disability continue.  As well, the 
stimuli or cues that activate the endogenous heal-
ing systems are not strictly “mental” (in the sense 
of being located in our psychological processes) 
but also social and their power and evocativeness 
derive from larger cultural systems of meaning. 
Ritual healing is not simply a matter of turning on 
endogenous self-regulatory or healing systems, 
but an ongoing process of modulation of experi-
ence that involves interpersonal interactions that 
can reinforce or undermine the therapeutic effect. 
In terms of placebo as healing ritual, this means 
that the impact of any intervention extends be-
yond the clinical interaction or moment of treat-
ment administration to include later processes of 
socially-mediated reflection, narration, re-inter-
pretation, and re-evaluation. 
Closer attention to particular systems of heal-
ing reveals other commonalities but also distinc-
tive features that may point to unique mecha-
nisms and sources of efficacy.  In a recent paper, 
Kaptchuk (2011) examines the parallels between 
the healing rituals of Navajo healing, acupunc-
ture and biomedical treatments.  Although these 
systems of healing differ profoundly in theory 
and practice, all three involve rituals that invoke 
positive expectations and engagement, affective-
experiential warranting of the power and author-
ity of the healer or the treatment, and cognitive-
perceptual transformations of illness experience. 
Kaptchuk suggests that healing rituals engender 
a receptive mode of participation that makes the 
participant more open to therapeutic suggestion. 
The nature of the rituals involved in biomedi-
cine influence the specific processes involved 
in clinical engagement, warranting of medical 
power and authority, and therapeutic transfor-
mations of experience.  Indeed, all three of these 
functions may be fused in a single medical act or 
intervention.  Naming a disease and prescribing 
a treatment are interventions that only doctors 
can perform, reflecting their specific social power 
and authority.  This social power, in turn, imbues 
the act of diagnosis and treatment with symbolic 
transformative power.  Simply labeling a symp-
tom or illness sets up a whole set of expectations, 
possibilities, and ways to think about and inter-
pret experience.  The consequences depend not 
only on the patient’s own expectations but also on 
how others respond to the diagnostic label.
The acts of prescribing and taking a pill occur 
in the context of a relationship between patient 
and physician, and the meaning of that relation-
ship and of the medication itself are embedded in 
larger cultural systems of meaning and practice. 
These practices involve social institutions, rules 
and norms that give biomedical treatments per-
formative efficacy.
Rituals are performative in the sense of bring-
ing into being specific social states of affairs and, 
as a byproduct, new configurations of the person. 
Performative speech acts are statements that cre-
ate the social reality they name as when, for exam-
ple, a justice of the peace pronounces a man and 
woman “husband and wife.” These rituals work 
because we all agree that the verbal act — per-
formed by the appropriate authority — transforms 
the person’s social status.  Similarly, physicians 
are assigned a specific type of social authority 
to make clinical diagnoses and prescribe medi-
cations or other types of medical treatment. 
Prescribing a treatment, whether active or pla-
cebo, conveys the message “you are being treated 
and will get better.” But the transformative effects 
of placebo occur not only because the doctor says 
this will help or declares that we are healed but 
because the patient undergoes cognitive, emo-
tional, experiential changes in response to con-
textual cues.  The biomedical intervention is usu-
ally not a declarative statement (like a faith healer 
emphatically saying.  “Now you are healed!”) but 
an implicit suggestion built into an intervention, 
and reinforced by statements framed as possibili-
ties  (“This should make you feel better”) or even 
questions (“Are you starting to feel better yet?”). 
These forms of suggestion have their own distinct 
pragmatic linguistic and psychological dynamics. 
Ultimately, healing rituals, including the 
techno-scientific practices of biomedicine, are 
not only performative acts but also emotionally 
engaging social events in which both healer and 
patient are active.  As such, healing involves pro-
cesses of thinking, feeling and imagining one’s 
way into new modes of experiencing.  A more 
complete account of the effects of symbolic heal-
ing will therefore require theories of the psy-
chophysiology of imagination and of the socio-
psychology of rhetorical persuasion (Kirmayer, 
2006).
Implications for clinical  
epistemology, ethics, and 
practice
The perspective on placebo as ritual performance 
sketched above has implications for the ways in 
which placebos are used in current biomedical 
research and diagnostic situations as well as for 
arguments recently advanced for the increased 
use of placebos in clinical care.
In clinical settings, placebos are sometimes 
used to support diagnostic claims about the na-
ture of a patient’s symptoms or condition (Fässler, 
Meissner, Schneider & Linde, 2010).  A positive 
response to placebo is interpreted as evidence that 
a patient’s symptoms and distress are exaggerated, 
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fabricated or psychogenic in origin.  It is, perhaps, 
not unreasonable to think that in forms of pathol-
ogy where beliefs and expectations play a central 
role (e.g., the vicious circles of a panic attack or 
hypochondriasis) an intervention that directly 
targets beliefs and expectations would have great 
efficacy.  Hence, to the extent that giving a pla-
cebo creates expectancy effects, we might expect 
greater responses in such conditions compared 
to illnesses where cognitive processes appear to 
play a less central role.  For example, those who 
respond to placebo analgesia are sometimes taken 
to have had symptoms of psychogenic rather than 
organic pain — notwithstanding the fact that the 
distinction between psychogenic and organic has 
been challenged by pain researchers who find that 
precisely the same central pathways are involved 
in pain of diverse origins (Gatchel, Peng. Peters, 
Fuchs & Turk, 2007; Melzack & Katz, 2007) and 
even from words or other social stimuli like inter-
personal rejection (Richter, Eck, Straube, Miltner 
& Weiss, 2010; Eisenberger, & Lieberman, 2004). 
A charitable interpretation of “psychogenic” 
would include causal effects of the range of psy-
chological and associated physiological influenc-
es discussed throughout this article, but the term 
is all too often used reductively and pejoratively 
to imply fictive influences (“merely” induced by 
psychological and personality influences) in con-
trast to “real” somatic ones (i.e., changes regis-
tered in and measured in terms of the chemistry 
and physiology of the body) (Kirmayer, 1988). 
However, the reasoning behind this diagnos-
tic use of placebos is fallacious for several rea-
sons.  As discussed earlier, placebo analgesia is 
mediated by the same endogenous pain control 
systems that may be activated in coping with pain 
of any origin.  Moreover, the processes involved 
in placebo responding occur with biologically 
active treatments and account for much of their 
efficacy.  The mechanisms of symptom control 
can be influenced by placebos regardless of the 
original cause of symptoms or illness.  Hence, the 
placebo response cannot be used diagnostically 
to show that an individual’s clinical condition is 
primarily due to psychological or social factors or 
mechanisms. 
The placebo response also cannot be viewed 
as a neutral baseline in clinical trials against 
which to measure the effectiveness of interven-
tions because, like any “active” agent or treat-
ment, it is also responsive to many contextual 
factors involved in clinical trials.  As a result, the 
mechanisms of placebo response overlap and in-
teract with the unique mechanisms of efficacy of 
the intervention.  At the same time, the clinical 
experimental context of the randomized clinical 
trial is a fraught situation that engenders complex 
expectancies of its own.  People may hope they 
are receiving active treatment but must contend 
with the possibility they are not (Kaptchuk et al., 
2009).  They thus may experience some mitigation 
of the benefit that might be achieved if they were 
confident they were receiving the best possible 
treatment.  In contemporary biomedical research 
and clinical settings, where risk and benefits are 
presented probabilistically, people must judge the 
likelihood that will get benefit.  Individuals may 
respond differently to these complex communi-
cations.  In a randomized trial, some participants 
may have diminished expectations due to the 
possibility of receiving an ineffective treatment; 
others may convince themselves they are receiv-
ing active treatment if they interpret idiosyncratic 
experiences as cues. 
The recognition that placebos “really work” 
might encourage their deliberate use in medical 
care.  But giving an biologically inactive treat-
ment while claiming it is active constitutes a type 
of deception.  Recently, Foddy (2009) has argued 
for the deceptive use of placebos when they would 
have a stronger beneficial effective than other 
available treatments.  He is able to advance this 
argument because he adopts a minimalist view of 
the practice of medicine in which the physician 
is a technician applying a one-off treatment.  But 
medicine involves building therapeutic relation-
ships to the clinician and to the health care sys-
tem as a whole.  It is this trusting relationship that 
the patient will bank on for help in the future. 
Arguments for the benefits of the deceptive 
use of placebos in medical care tend to be based 
on a narrow, instrumental view of the doctor–pa-
tient relationship as well as limited understanding 
of the nature of placebo responding.  The clinical 
encounter involves dimensions of empathic rec-
ognition, relationship building, trust, education 
and advocacy that may contribute to the efficacy 
of specific treatment interventions, including 
placebos (Benedetti, 2011).  Kaptchuk and col-
leagues developed a paradigm for decomposing 
elements of the placebo response (comparing, 
for example, sham acupuncture with and without 
various ritual components (e.g., warm and atten-
tive relationship to practitioner) (Kaptchuk, et al., 
2008; Kelley et al., 2009).  Each element added 
something to the effectiveness of a treatment, 
with a warm and supportive patient–practitioner 
relationship probably accounting for the largest 
single component.  This observation has impor-
tant implications for the potential use of placebos 
in clinical care.  If the clinician–patient relation-
ship is actually the most powerful component of 
a placebo response, protecting and preserving 
the relationship is crucial and bad faith may ulti-
mately destroy the positive effect.  Of course, it is 
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possible to have a lot of faith in a warm and per-
sonable or authoritative and rhetorically powerful 
charlatan and, indeed, go to one’s grave secure in 
the illusion one is being well cared for, but again, 
any wholesale use of placebos occurs in a larger 
social context where such hucksterism will be 
damaging to others and to the adaptive function-
ing of a whole community. 
Lying and subterfuge are corrosive to trust. 
Discovering that the doctor “lied” will damage fu-
ture collaboration (both with this doctor and with 
others by association).  Indeed, if it was widely 
known that doctors give placebos, then the ef-
fect of every existing treatment would be reduced 
since people could always suspect they were re-
ceiving an “ineffective” treatment.  If patients 
knew that it was always a possibility that they 
were being given placebos, this might erode the 
efficacy of treatments in general (but see Martin 
& Katz, 2010), as well as undermining confidence 
in the trustworthiness of doctors, and in the reli-
ability of the institution of medicine as a whole. 
In the end, any analysis of the effects of deception 
that remains at the level of the individual is inad-
equate because medicine is also a social institu-
tion: health care contributes to the fabric of civil 
society.  Knowing that doctors in general may lie, 
would damage trust in individual physicians, in 
the whole institution of medicine, and potentially 
also in broader social institutions that underwrite 
medical care. 
The whole discussion of deception may be 
moot because, in fact, placebos demonstrably do 
not depend on deception (Kaptchuk et al., 2010). 
Moreover, there are ways to openly endorse and 
encourage placebo effects without engaging in de-
ception.  For example, referring to “the power of 
the mind” is both a plausible and culturally con-
sonant non-deceptive explanation of a placebo ef-
fect that is, in fact, reinforced in certain cultural 
and religious contexts. 
In summary, the context effects that underlie 
placebo responding are important components in 
any effective medical treatment.  Giving people 
positive expectations, realistic hope and opti-
mism is crucial both for strengthening the heal-
ing relationship and insuring treatment efficacy. 
Prescribing the best effective treatment will also 
maximize placebo effects, enhance expectations 
and increase the potential for positive respond-
ing in the future.  However, there is no ethical or 
pragmatic justification for the use of subterfuge 
or deceit in the delivery of placebos because the 
same beneficial effects can be achieved by truthful 
communication that also strengthens and main-
tains a working alliance and confidence in the 
health care system. 
Conclusion: Embodiment, 
enactment and the rhetorics 
of healing
The idea of placebo is a biomedical construc-
tion because it is only in the disenchanted world 
of scientific medicine that the therapeutic ef-
fectiveness of words, symbols and rituals can 
be viewed as suspect.  When only direct chemi-
cal or physical effects are recognized as causal 
agents then the power of symbolic interventions 
requires special pleading.  Placebo research has 
clearly shown that symbolic stimuli and positive 
expectations set in motion specific physiological 
processes that mediate a wide range of placebo ef-
fects.  These mechanisms vary according to the 
type of symbolic stimulus or context and the re-
sultant expectations.  For example, under specific 
circumstances, symbolic interventions may acti-
vate endogenous opioid pain control systems to 
produce analgesia, dopaminergic reward systems 
to produce elevated mood, and immunologic re-
sponses to reinforce host resistance to infection. 
“Placebo” names a social situation not a sub-
stance.  Placebo responding reflects the ways that 
people think, act, feel and respond physiological-
ly to an intervention they believe and expect will 
be of help.  Defined in this way, placebo responses 
clearly are based on beliefs and expectations.  But 
beliefs and expectations themselves are complex 
and only partially dependent on individual cog-
nitive processes.  Beliefs and expectations may 
follow from bodily experiences, enactments, con-
texts and commitments more than any explicit 
cognitive model.  Indeed, these same aspects of 
embodiment may give rise to placebo responses 
in the absence of explicit beliefs and expectations. 
A view of biomedical treatment as ritual heal-
ing leads us toward a model that bridges the psy-
chological view of placebo responding as based 
on endogenous healing processes with a social 
view that focuses on cultural models of affliction 
and healing.  Mediating these two poles of expe-
rience are symbolic (especially metaphoric) pro-
cesses of communicative action that link bodily 
processes and social discourse.  The mechanisms 
of ritual healing involve both sociopsychological 
(persuasive, rhetorical) and psychophysiological 
processes of imaginative engagement.  Unpacking 
the mechanisms that subserve these processes 
can provide the basis for an integrative theory of 
symbolic healing that includes the many varieties 
of placebo response alongside the social, psycho-
logical and biological processes that accompany 
every biomedical intervention. 
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